Overview

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Adapalene